Gain Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $20.8M | $10.4M | $11.8M | $7.3M | $36.9M | $7.5M |
| Accounts Receivable | — | — | — | — | — | $8.5K |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $22.2M | $11.6M | $17.8M | $21.1M | $37.7M | $9.0M |
| Property, Plant & Equipment | $74.9K | $103.6K | $126.0K | $144.4K | $106.0K | $29.6K |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $22.8M | $12.1M | $18.6M | $24.1M | $39.0M | $9.6M |
| Liabilities | ||||||
| Accounts Payable | $825.0K | $946.3K | $1.3M | $1.6M | $560.5K | $961.5K |
| Total Current Liabilities | $3.4M | $3.9M | $4.9M | $4.1M | $2.6M | $2.1M |
| Long-Term Debt | $300.1K | $328.3K | $449.1K | $495.3K | $590.5K | $715.7K |
| Total Liabilities | $4.3M | $4.8M | $6.0M | $5.2M | $4.2M | $3.4M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-81.2M | $-60.8M | $-38.5M | $-20.9M | $-7.0M | $-3.5M |
| Total Stockholders' Equity | $18.6M | $7.3M | $12.6M | $18.9M | $34.8M | $6.2M |